A Partnership in Care
Referred to Dr. Stotland at North York General (NYG), Aneta discovered not only world-class care but a deeply person-centred team. She began a course of aggressive radiation and oral chemotherapy designed to shrink the tumour. To everyone’s astonishment, it disappeared entirely, leaving only scar tissue — a rare outcome that opened the door to a difficult but hopeful choice.
Traditionally, even when a tumour vanishes after chemoradiation, standard practice is still to surgically remove the affected section of the rectum or colon. But Dr. Stotland was leading a groundbreaking clinical trial at NYG for patients like Aneta who had a complete clinical response. Known as a “watch and wait” approach, the trial allowed carefully selected patients to postpone surgery under strict medical supervision.
A Groundbreaking Path Forward
Participants, including Aneta, were closely monitored with regular MRIs, CT scans, bloodwork, and frequent check-ups. If there was any sign of the disease returning, they would move to surgery immediately. This intensive monitoring gave Aneta the confidence to choose the trial and preserve her quality of life without sacrificing safety.
“Dr. Stotland treated me as a partner in my care,” she says. “He shared research, walked me through every option, and made sure the final decision was mine.” NYG’s nurse navigator reinforced that support, coordinating appointments and providing steady reassurance for Aneta and her family.